Tech Company Financing Transactions
Foldax Funding Round
Foldax, operating out of Salt Lake City, received $20 million from MemorialCare Innovation Fund, Angel Physicians Fund and BioStar Ventures.
Transaction Overview
Company Name
Announced On
6/23/2020
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series D
Investors
MemorialCare Innovation Fund (Lead Investor) (Brant Heise)
Proceeds Purpose
The use of funds will continue to add patients to the recently completed EFS clinical trial for the company's surgical aortic Tria biopolymer heart valve, initiate and enroll patients into the clinical trial for the surgical mitral valve, as well as continue development of the transcatheter aortic valve replacement (TAVR) device for the first-in-man clinical study.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
825 N. 300 W. NE-500
Salt Lake City, UT 84103
USA
Salt Lake City, UT 84103
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Foldax, Inc. is taking the lead in the development of heart valves with the goal of improving hemodynamic performance similar to natural human valves.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Ken Charhut
Chief Executive Officer
Frank Maguire
VP - Marketing
Michael Numamoto
VP - Operations
Paul Hammond
VP - R & D
Jason Beith
VP - Regulatory Affairs
Michele Lucey
Browse more venture capital transactions:
Prev: 6/23/2020: Cedar venture capital transaction
Next: 6/24/2020: Quidnet Energy venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. All VC database entries reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs